Cairn Investment Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Cairn Investment Group's LLY Position: Q1 2026 in Review
Cairn Investment Group reduced its Eli Lilly (LLY) stake by 6.7% in Q1 2026, selling an estimated $203K and leaving 2,785 shares worth $2.56M. The position accounts for 1.27% of the portfolio, ranked #28.
Cairn Investment Group first reported a position in LLY in Q4 2019 and has held it in 26 quarters since. The position peaked at $3.3M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Cairn Investment Group held 2,785 shares of Eli Lilly worth $2.56M as of Q1 2026.
- Cairn Investment Group sold 200 Eli Lilly shares in Q1 2026, an estimated $203K.
- Eli Lilly made up 1.27% of Cairn Investment Group's portfolio in Q1 2026, its #28 holding.
- Cairn Investment Group first reported a position in Eli Lilly in Q4 2019 and has held it in 26 quarters since.
- Cairn Investment Group's Eli Lilly position peaked at $3.3M in Q2 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Cairn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.